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Late survival and freedom from myocardial infarction
were determined for 192 patients with coronary artery
disease and depressed left ventricular ejection fraction
at rest (:535%) determined by biplane angiography who
were evaluated between 1970 and 1977. Seventy-seven
patients had coronary artery bypass grafting and 115
patients were treated medically and were considered sur-
gical candidates. The medical and surgical groups were
comparable in all baseline characteristics examined ex-
cept frequency of three vessel disease and angina pec-
toris, which occurred in a significantly greater percent
of the surgically treated patients (p < 0.01). Only three
medically treated patients (2.6%) underwent coronary
bypass grafting in the follow-up period.
Seven year actuarial survival was 63% in the surgical
and 34% in the medical group (p < 0.001). Ninety-three
percent of patients in the surgical group and 81% of
those in the medical group were free of nonfatal myo-
cardial infarction (p = 0.01), and 62 and 33%, respec-
tively, were alive and free of myocardial infarction
Coronary artery bypass grafting has been conclusively shown
in both observational studies and prospective randomized
trials to be more effective than medical therapy in relieving
the symptoms of angina pectoris and in improving the func-
tional status of patients with significant coronary artery dis-
ease and preserved ventricular function. With the exception
of patients with left main coronary artery disease, the results
of randomized trials comparing the effect of medical and
surgical therapy on survival and nonfatal coronary events
are inconclusive (1-4). Only the European Coronary Sur-
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(p < 0.001) at 7 years. Significant differences in survival
favoring surgical treatment were observed for the sub-
sets of patients with an ejection fraction of 25% or less
(p = 0.0002) and 26 to 35% (p = 0.01), and for the
subsets with three vessel coronary disease (p < 0.001),
normal left ventricular end-diastolievolume(:5100 ml/m')
(p = 0.005) and elevated end-diastolic volume (>100
ml/m2)(p = 0.001). After adjustment for other impor-
tant prognostic variables, the type of treatment re-
mained significant in predicting the relative risk (medical
to surgical) of mortality at 5 and 7 years (2.58 and 2.12,
respectively).
These data corroborate the trends observed in several
randomized trials of medical and surgical therapy in
patients with abnormal left ventricular function. If hos-
pital mortality for coronary artery bypass grafting is less
than 5%, substantial benefit can be anticipated for the
majority of patients with depressed ventricular function.
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gery Study Group (3) demonstrated significantly increased
survival in patients with three vessel disease treated sur-
gically. These major studies have focused on patients with-
out substantial impairment of left ventricular function: an
ejection fraction greater than 30% in the Cooperative Study
of Unstable Angina (I), greater than 25 to 30% in the Vet-
erans Administration Cooperative Study (2), greater than
50% in the European Coronary Surgery Study (3) and greater
than 35% in the Coronary Artery Surgery Study (CASS)
(4). However, both the Veterans Administration Study and
the CASS demonstrated trends in survival favoring surgical
treatment in patients with three vessel coronary disease and
moderate impairment of ventricular function (ejection frac-
tion 25 to 50%).
Thus, the indications for coronary artery bypass grafting
in such patients and those with more severe impairment of
ventricular function remain incompletely defined. In view
of the lack of sufficient data from randomized studies, we
reviewed the results of surgical and medical therapy for a
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Patients
Table L Reasons for Medical (versus surgical) Therapy in the
115 Patients
two or more majorcoronary arteries or their primary branches
which could accept grafts. The remaining liS patients had
two or more arteries suitable for grafting and constitute the
medical group. The decision for initial surgical or medical
therapy was made jointly by the attending physicians and
the patients. The reasons for initial medical therapy in the
115 patients are.listed in Table I. Using our current criteria,
all of the 18patients who were originally classifiedas having
unsuitable coronary artery anatomy wereconsidered surgical
candidates.
Baseline characteristics. The pertinent baseline, clini-
cal and angiographic characteristics of the 77 surgical and
lIS medical patients are shown in Table 2. Unstable angina
was defined as recent onset of angina or a change in the
pattern of pain (frequency, severity and duration), or onset
of rest or nocturnal angina, or both, in the 3 months pre-
ceding angiography. Congestive failure was defined as ex-
crtional dyspnea plus paroxysmal nocturnal dyspnea, or-
thopneaor edema. A history of myocardial infarction required
that the patients had been informed by a physician of a
definite infarction or the presence of Qwaves on the baseline
electrocardiogram.
Follow-up, Follow-up information was obtained by yearly
visits to an outpatient facility at our medical center or by
telephone interview of the patients and their physicians at
similar intervals. Follow-up information was available for
76 (99%) of the patients treated surgically and 112 (97%)
of those treated medically. The mean duration of follow-up
was 62 months in the surgical group and 45 months in the
medical group. The causes of death were determined by
postmortem examination when available, by death certifi-
cate or by a statement from the attending physician. The
occurrence of nonfatal myocardial infarction was deter-
mined from a hospital record that showed a diagnosis of
acute myocardial infarction and from electrocardiograms
obtained at the annual follow-up visits using selected criteria
from the Minnesota code (7) .
Statistical methods. Comparisons of the surgical and
medical groups were made using standard life table methods
(8) . Exposure was calculated from the time of cardiac cath-
eterization in both groups. Fifty percent of the surgically
No. %
54
16
14
12
4
100
62
III
16
14
5
115
CASS '" Coronary Artery Surgery Study.
Poor left ventricular function
Coronary anatomy unsuitable for surgery
Asymptomatic
Refused operation
Randomized (CASS)
Total
Methods
Patient selection. BetweenJanuary 1970and December
1977. a total of 6.600 patients were prospectively entered
into the Ischemic Heart Disease Registry at the University
of Alabama Medical Center in Birmingham. This registry
included all patients who had coronary arteriography at the
medicalcenter during this interval and the subset who under-
went coronary artery bypass grafting. It also included pa-
tients having coronary artery bypass' grafting who had pre-
operative coronary arteriography performed elsewhere.
Stenoses of 50% or greater of the left main coronary artery
and of the three major coronary arteries or their primary
branches at angiography were considered significant. The
patients were classified into three anatomic subsets: one,
two and three vessel disease. Patients with isolated left main
coronary artery stenosis were classified as having three ves-
sel disease if the right coronary artery had a significant
stenosis, and as having two vessel disease if it did not.
Biplane ventriculography was performed in approxi-
mately 1.500 ofthe 6.6()(J patients . Left ventricular volumes
(end-systolic and end-diastolic) and left ventricular ejection
fraction were calculated using the area-length method of
Dodge et al. (5) . Two hundred ten of these patients had
signifi cant coronary artery disease and ventriculogramssuit-
able for analysis with a left ventricular ejection fraction of
35% or less; these constitute the study group. Patients with
associated valvular heart disease, discrete areas of akinesia
or dyskinesia of the left ventricle that might requireexcision,
rupture of the ventricular septum, ascending aortic aneu-
rysms or congenital cardiac lesions were excluded from the
analyses.
Surgically treated patients. Seventy-seven of the 210
patients underwent coronary artery bypass grafting. Disa-
bling angina pectoris was the most common indication for
operation. Patients with little or no angina, with or without
symptoms of congestive failure, but with areas of viable
myocardiumsupplied by stenotic arteries were also operated
on. Advanced age was not a contraindication to operation.
The details of the anesthetic, intraoperative and postoper-
ative management of patients having coronary artery bypass
grafting at our institutionduring the study interval have been
previously described (6).
Medically treated patients. The coronary arteriograms
of the remaining 133 patients were retrospectively reviewed
to determine the suitability of the coronary arteries for by-
pass grafting using current criteria. Eighteen patients were
excluded from further analysis because of the absence of
7 year period for patients with depressed ventricularfunction
defined by the left ventricular ejection fraction and end-
diastolic volume at rest. The principal outcome events ex-
amined were survival and freedom from nonfatal myocardial
infarction.
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Table 2. Baseline Characteristics of the Medically and Surgically Treated Patients
Surgical
(n = 77)
Medical
(n = 115) p Value
Clinical variables
Mean age (yr)
% Male
% Angina
% Unstable angina
% Congestive failure
% Previous myocardial infarction
% Hypertension
% Diabetes
Hemodynamic Variables
Mean ejection fraction (% ± SO)
% Three vessel disease
Mean number of diseased vessels
% Left main coronary artery stenosis
54
88
65
52
21
92
38
12
0.27 ± 0.07
64
2.8
3
54
89
37
29
26
88
47
9
0.25 ± 0.07
57
2.4
o
NS
NS
<0.001
<0.002
NS
NS
NS
NS
NS
<0.01
NS
NS
NS = not statistically significant (p > 0.05).
Figure 1. Cumulative survival of the 77 surgically treated and
115 medically treated (Rx) patients. Numbers in parentheses are
the patients alive at the end of that interval. Seven year survival
rates were 63 and 34%. respectively. SEM = standard error of
the mean.
treatment were performed for the 5 and 7 year intervals
using likelihood ratio tests and compared with the chi-square
distribution. The survival and event-free survival curves for
all patients (Figs. I to 12) extend to 7 years. The dashed
lines at the ends of these curves in Figures 3, 6 and 10
encompass an interval in which there were no deaths. The
vertical bars represent the standard error.
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treated patients underwent coronary artery bypass grafting
within 60 days of catheterization and 80% within 90 days;
the median interval from catheterization to operation was
45 days. No patients for whom surgical treatment was ad-
vised died while awaiting operation. The problems related
to retrospective comparisons of surgically and medically
treated patients with coronary artery disease are well rec-
ognized and have been addressed in detail in recent publi-
cations from the Coronary Artery Surgery Study (CASS)
(9,10). Because no patient in our study died while awaiting
surgical treatment and a high percent of the surgically treated
patients were operated on within 90 days of catheterization,
use of the date of catheterization as the date of initial ex-
posure for both groups appears justified.
Survival, freedom from nonfatal myocardial infarction
and survival free of myocardial infarction (event-free sur-
vival) were determined for both groups. In the analyses of
freedom from infarction, deaths were treated as censored
observations (II). In the analyses of event-free survival,
patients were withdrawn at the time of the first event (death
or myocardial infarction). At the date of the last inquiry
(April 1982), three of the medically treated patients had
undergone coronary artery bypass grafting 25, 31 and 35
months, respectively, after catheterization. They were with-
drawn from the medically treated group at these intervals.
Differences in the baseline characteristics of the patients
in the two groups were analyzed using chi-square techniques
for discrete variables and the two sample t test for continuous
variables. The observed differences in survival and freedom
from infarction between the surgical and medical groups
were tested by the log rank (Mantel-Hantzel chi-square) test.
The proportional hazards method of Cox (2) was used to
adjust for covariates of survival. Analyses of end point
events adjusted for the covariates angina, unstable angina.
ejection fraction, left ventricular end-diastolic volume, year
of catheterization, number of vessels diseased and type of
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Figure 2. Cumulative survival of the 77 surgically treated and
115 medically treated patients excluding deaths from causes other
than cardiovasculardisease. Seven year survival rates were 70 and
42%, respectively.
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Figure 3. Cumulative survival of 30 surgically treated and 53
medically treated patients with an ejection fraction of 25% or less.
Seven year survival rates were 46 and 15%, respectively .
Figure 4. Cumulative survival of the 47 surgically treated and 62
medicallytreated patients with an ejection fraction between26 and
35%. Seven year survival rates were 73 and 50%, respectively.
vival rates were 82 and 64%, and the 7 year rates 73 and
50% (p = O.OI)(Fig. 4) .
Ventricular volume. Left ventricular volume determi-
nations with normalization for body surface area were avail-
able for 74 (96 %) patients in the surgical group and 105
(91 % ) of those in the medical group. A left ventricular end-
Results
Survival
Overall survival. There was I hospital death among 77
surgically treated patients (1.3%) . This patient had three
vessel disease and an ejection fraction of less than 25%.
The cumulative survival rates of the 77 patients treated
surgically and the 115 patients treated medically are shown
in Figure I. The 5 year survival rate was 76 and 45%, and
the 7 year rate was 63 and 34% for the surgical and the
medical groups. respectively (p < 0.(01). When deaths
from causes other than cardiovascular disease were ex-
cluded , respective survival at 5 years was 80 and 50% and
at 7 years 70 and 42% for the surgical and the medical
groups (p < 0.00 I) (Fig. 2) . Sudden death (death within
24 hours of onset of symptoms) occurred in 9 (11.8%) of
the 76 surgically treated hospital survivors and in 27 (23 .5%)
of the 115 medically treated patients (p = 0.04).
Effect of angiographic variables. Ejection frac-
tion. Thirty surgically treated patients and 53 medically
treated patients had an ejection fraction of 25% or less
(mean ± SO = 19.6 ± 5.2 and 18.4 ± 5.2, respectivelyjtp
= NS) . Survival at 5 years was 68% for the surgically
treated patients and 21% for the medically treated patients;
at 7 years these rates were 46 and 15%, respectively (p = '
0.(02) (Fig. 3). For the 47 surgically treated patients and
62 medically treated patients with an ejection fraction be-
tween 26 and 35% (mean ± SO = 31.1 ± 3.3 and 30.5
± 3.2, respectively) (p = NS) , the respective 5 year sur-
100
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Figure 5. Cumulative survival of the48 surgically treated and 85
medically treated patients with an abnormally elevated left-ven-
tricular end-diastolic volume ( > 100 ml/nr' of body surface area) .
Seven year survival rates were 51 and 31 %, respectively .
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Figure 6. Cumulative survival of the26surgically treated and20
medically treated patients with a normal left ventricular end-dia-
stolic volume. Seven year survival rates were 88 and 56%,
respectively.
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Figure 7. Cumulative survival of the 57 surgically treated and64
medically treated patients with three vessel disease. Seven year
survival rates were 61 and 25%. respectively.
100 (56)
Infarction-free survival. Survival free of myocardial
infarction at 5 years was 75% for the entire surgical and
43% for the entire medical group, and at 7 years was 62
and 33%, respectively (p < 0.(01) (Fig. 9). For the subset
of patients with an ejection fraction of 25% or less, the 5
p=O.OOOOOOS
(15)
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·n=64
• =surgical Rx
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40
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Myocardial Infarction
Nonfatal infarction. Follow-up information on the in-
cidence of nonfatal myocardial infarction was available for
75 (97%) patients in the surgical group and 103 (90%) of
those in the medical group. Fifteen patients (3 in the surgical
group and 12 in the medical group) had one or more in-
farctions. None of the infarctions in the surgical group oc-
curred in the early postoperative period. At both 5 and 7
years, 93% of patients in the surgical group and 81% of
those in the medical group were free of nonfatal infarction
(p = 0.0 I )(Fig. 8).
diastolic volume of 100 ml/rrr' body surface area or less
was considered normal. Forty-eight (65%) surgically treated
patients and 85 (81 %) medically treated patients had an
abnormal end-diastolic volume (mean ± SO = 145 ± 42
and 150 ± 47 rnl/rrr', respectively)(p = NS). Survival rates
at 5 years were 71% for the surgical group and 40% for the
medical group and at 7 years. 51 and 31%, respectively
(p = O.OOI)(Fig. 5). For the 26 patients treated surgically,
and the 20 patients treated medically with a normal end-
diastolic volume, survival at 5 years was 88 and 56%, and
at 7 years 82 and 46%, respectively (p = 0.OO5)(Fig. 6).
Extent of coronary artery disease. Fifty-seven patients
in the surgical group and 64 inthe medical group had three
vessel disease. Survival at 5 years was 75 and 31% and at
7 years 61 and 25%, respectively, for the two groups (p <
O.OOI)(Fig. 7).
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Figure 9. Cumulative survival free of nonfatal myocardial in-
farction for the 77 surgically treated and 115 medically treated
patients. Seven year survival rates were 62 and 33%. respectively.
(22)
(21)
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Figure 8. Cumulative incidence of freedom from nonfatal myo-
cardial infarction for 75 surgically treated and 103 medically treated
patients with available follow-up information. Seven year rates
were 93 and 81%. respecti vely.
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• =surgical Rx
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year event-free survival rates were 68 and 21%. and the 7
year rates were 46 and 15%, respectively (p = 0.0003)
(Fig. 10). For the subset with an ejection fraction between
26 and 35%, the 5 year event-free survival rates were 82%
in the surgical group and 65% in the medical group. and at
7 years were 73 and 50%, respectively (p = 0.02)(Fig.
II). For the 57 patients in the surgical group and the 64
patients in the medical group with three vessel coronary
disease, the respective event-free survival rates were 75 and
31% at 5 years and 61 and 23% at 7 years (p < 0.001 )(Fig.
12).
Multivariate Analyses
Data from 179 of the 192 patients were analyzed using
the proportional hazards model of Cox (12) at 5 and 7 year
intervals. After adjustment for other important prognostic
variables. the type of treatment (surgical or medical) re-
mained statistically significant in predicting the relative risk
of mortality at 5 and 7 years (Table 3). The relative risk
(medical to surgical therapy) was 2.58 at 5 years and 2.12
at 7 years. Adjustment of ventricular volumes to calculated
body surface areas did not alter the results.
Discussion
Role of left ventricular dysfunction. Left ventricular
function is the most important independent predictor of sur-
vival for patients with coronary artery disease treated non-
surgically (13,14). It is also an important predictor of in-
Table 3. Cox Regression Analysis and Proportional Hazard Functions
5 Year Coefficients 7 Year Coefficients
Covariates
Treatment
Excluded
Treatment
Included
Treatment
Excluded
Treatment
Included
Angina
Unstable angina
Ejection fraction
Ventricular end-diastolic volume
Year of catheterization
Number vessels diseased
Treatment (medical. surgical)
Test for overall model
(degrees of freedom)
Test that treatment is significanl
p Value
Relative risk (medical 10 surgical)
0.148
0.337
-0.028
0.006
1.007
0.438
x' - .12.6
(61
x' = 6.13(um
2.58
0.160
0.292
-0.028
0.005
·0.074
0.465
-O.'.WJ
X' ~ 38.8
(7)
0.185
- 0.513
-0.025
0.005
··0.076
0.293
x' = 30.9
(6)
x' = 4.76
0.029
2.12
0.200
-0.483
-0.026
0.005
-0.054
0.310
-0.753
X' = 35.7
(7)
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Figure 10. Cumulative survival free of nonfatal myocardial in-
farction for the 30 surgically treated and 53 medically treated
patients with an ejection fraction of 25% or less. Seven year sur-
vival rates were 46 and 15%, respectively.
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Figure 11. Cumulative survival free of nonfatal myocardial in-
farction for the 47 surgically treated and 62 medical treated patients
with an ejection fraction between 26 and 35%. Seven year survival
rates were 73 and 50%, respectively.
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hospital and late mortality after coronary artery bypass graft-
ing (15-18). Rest left ventricular ejection fraction and left
ventricular wall motion score are two variables that have
been used to quantitate the severity of left ventricular dys-
function. An ejection fraction at rest of 25% or less and a
left ventricular wall motion score of 17 to 30 (normal =
5) have been associated with poor long-term survival in
patients treated medically and are more powerful predictors
of survival than is the extent of coronary artery disease (4).
Assessment of the relative efficacy of medical and sur-
gical therapy of coronary artery disease can be best accom-
plished by prospective randomized trials. To date, no such
trials have been performed in patients with substantially
impaired ventricular function using left ventricular ejection
fraction or some other precise descriptor of ventricular func-
tion such as the wall motion score. The randomized portion
of the Coronary Artery Surgery Study (CASS) contains a
subset of patients with three vessel disease and left ventric-
ular ejection fraction between 35 and 49% for whom a trend
(not statistically significant) in favor of surgical treatment
was observed (4).
Natural history and observation studies. In the ab-
sence of randomized trials, useful information may be ob-
tained from natural history and observational studies pro-
vided that the relevant clinical and angiographic variables
of the groups under study are documented. A summary of
the results of nonoperative therapy in five published
(10,14,19-21) series of patients with a left ventricular ejec-
tion fraction of 35% or less is shown in Table 4. Despite
similar degrees of left ventricular dysfunction, the patients
in these series differed in other important characteristics.
Patients with left ventricular aneurysm were included in
some series and excluded in others. Not all patients in each
series were considered suitable candidates for bypass graft-
ing. The number of patients who crossed over to surgical
therapy during the follow-up intervals, primarily because
of worsening symptoms (usually angina pectoris), varied
from 9 to more than 33%. Because patients managed non-
operatively who have "progressive" symptoms have been
shown by Harris et al. (19) to have a higher ischemic death
rate in the early years after diagnosis than that of patients
with "nonprogressive" symptoms, withdrawal from the
medical group of substantial numbers of patients whose
symptoms worsen may yield more favorable survival curves
for the remaining patients. These curves will not accurately
reflect the true natural history of the patients originally under
study. These and possibly other undetected differences could
account for the widely differing survival rates observed and,
as emphasized by Mock et al. (14), demonstrate the un-
suitability of such survival data for comparison with the
survival of groups of patients with similar degrees of left
ventricular dysfunction treated surgically.
In the present study, all patients in the medical group
were considered suitable candidates for bypass grafting.
The patients in the medical and surgical groups were eval-
uated and treated concurrently by the same physicians and
surgeons during the 7 year interval. Patients who were be-
lACC Vol. 5. No. 5
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Figure 12. Cumula tive survival free of no nfa ta l myocard ia l in-
farc tio n fo r the 57 surg ica lly treated and 64 med icall y treated
pat ients with three vesse l co ro nary disease . Seven ye ar surv iva l
rates were 61 and 23 %. res pective ly .
lieved to have a ventricular aneurysm or scar that would
require excision were excluded. Only three patients (2.6%)
in the medical group underwent bypass grafting in the fol-
low-up interval. and they each had received medical therapy
for at least 2 years. Thus, the survival data of our medical
group may be more representative of the natural history of
patients with severely depressed left ventricular function
than those from the previously published series.
Baseline characteristics. In our study, differences in
the baseline characteristics of the medically and surgically
treated patients did exist. The surgically treated patients had
a significantly greater prevalence of angina, unstable angina
and three vessel disease. Similar differences were observed
by Vlietstra et al. (17). Faulkner et al. (20) and the CASS
investigators (10) for patients in the nonrandomized registry
portion of the study with an ejection fraction of 35% or less
who had medical or surgical therapy. In the CASS (10),
when these and other covariates were adjusted by multi-
variate analysis, surgical treatment was shown to signifi-
cantly improve survival. Similarly, in our study, surgical
therapy was a significant independent predictor of survival
in the multivariate analyses (Table 3). Furthermore, when
patients with threee vessel disease were compared, survival
was significantly greater in the surgical group (Fig. 7). It
is possible that other undetected differences exist between
our medical and surgical groups which could have biased
selection of patients for one or the other form of therapy
and affected survival. However, the major prognostic vari-
ables currently recognized as significant were considered
simultaneously in the analyses of survival, and the results
were consistent throughout the period of follow-up.
Hospital mortality. Hospital mortality for the surgical
group was low (1.3%). However, this was a nonconsecutive
series of patients, since other patients with left ventricular
dysfunction that was not quantitated by biplane ventricu-
lography were operated on during the period of study. Data
from the CASS (18) for 5,024 patients operated on between
(14)
p=O.OOOOOOI
I I I I I
2 3 4 5 6
Years After Catheterization
o =medical Rx
n=64
e= surgical Rx
n=57
f=5EM
40
80
Table 4. Previous Studies on Surv ival of Medi cally Treated Patients With Depressed Ventricular Fun ct ion
Suitability
Inclusion of all
of Patients Patients Cross-
Ejection With for Over Cumulative Survival (%)
No. of Fraction Ventricular Bypass Rate
Patients (%) Aneurysm Grafting 1%) 4 Year 5 Year 6 Year
Harris et al. (9) 152 < 25· Yes No 10 44 38 33
1967 to 1978
Faulkner et al. (20) 70 < 30 No No t 7 t t
1969 to t975
Alderman et al. (2 1) 48 ::s35 No t t t 20 t
1973 to 1978
Mock et al. ( 14) 909 < 35 t No > 33 58 52:1: t
(CASS)
1975 to 1979
Alderman et al. (10) 420 <35~ Yes Yes 9 6111 54 46
(CASS)
1975 to 1979
· Estimated (diffusely abnormal contractions): t not stated; t unpubtished data: ~p l us wall motion score ~ 12: II survival curve adjusted for other
prognostic variables.
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August 1975 and December 1978 showed a hospital mor-
tality rate of 2.5% for 404 patients with an ejection fraction
of 39% or less and 4.7% for 107 patients with an ejection
fraction of 29% or less. These data were obtained from 15
centers of varying size and distribution in North America,
including the University of Alabama in Birmingham, and
are probably most representative of the results of bypass
grafting during that time period. As emphasized by Ald-
erman et al. (10), hospital mortality for the subset of patients
with an ejection fraction of 35% or less must not exceed
the 7% value observed in the CASS registry to demonstrate
a significant difference in survival in favor of surgical treat-
ment. With current operative techniques, including the use
of hypothermic cardioplegia for intraoperative myocardial
protection which was used infrequently before 1977 (6),
hospital mortality for elective coronary artery bypass graft-
ing in this subset of patients with left ventricular dysfunction
(ejection fraction :S:35%) should not exceed 5%.
Prognostic value of ejection fraction. The severity of
left ventricular dysfunction as assessed by the left ventricular
ejection fraction had an adverse effect on survival in both
the medically and surgically treated groups (Fig. 3 and 4).
Similar differences were observed in the CASS nonrandom-
ized registry of patients with an ejection fraction of 35% or
less treated medically and surgically (10). In every subset
examined in our study and in the CASS, the surgically
treated patients had a higher survival rate. The differences
were statistically significant, however, only for the subset
of patients with an ejection fraction of 25% or less (CASS
and our study) and in our study for the subset with an ejection
fraction between 26 and 35%.
A major uncertainty regarding the use of depressed left
ventricular ejection fraction as an indicator of impaired left
ventricular function is the inability of this variable to dif-
ferentiate myocardium that is depressed because of reversible
ischemia from myocardium depressed by fibrosis from pre-
vious infarction. Furthermore, these conditions may coexist
in the same patient. More sensitive tests for the detection
of reversibly ischemic myocardium, such as measurement
of ejection fraction during exercise or scintigraphic studies
to distinguish between ischemia and fibrosis, were not avail-
able in the early years of the study and were used only
selectively in the later years, resulting in insufficient num-
bers for statistical comparison. Elevated end-diastolic vol-
ume may be a more specific indicator of the presence of
myocardial fibrosis in patients with coronary artery disease
than is the ejection fraction at rest, and in univariate analyses
it has been associated with poor long-term survival (13). In
our study, the late survival rate of both medically and sur-
gically treated patients with an elevated left ventricular end-
diastolic volume was lower than that for the corresponding
patients with a normal end-diastolic volume (Fig. 5 and 6).
Significantly greater survival of the surgically treated pa-
tients with an elevated end-diastolic volume suggests that
bypass grafting may be beneficial in patients with substantial
left ventricular fibrosis. The specific mechanism for this
beneficial effect is unknown, but it may relate to the pre-
vention or delay of additional myocardial fibrosis afforded
by the bypass grafts.
The survival ofpatients with depressed ejection fraction
and three vessel coronary disease treated medically was
lower than that of the medically treated group as a whole
(Fig. I and 7). The difference in survival between medically
and surgically treated patients in this subgroup was highly
significant (Fig. 7). In the randomized portion of the CASS
(10), the difference in survival between medically and sur-
gically treated patients with three vessel disease and a lesser
degree of left ventricular dysfunction (ejection fraction 35
to 49%) followed up for 5 years approached statistical sig-
nificance (p = 0.063).
The incidence ofnonfatal myocardial infarction was sig-
nificantly lower in the surgically treated group (Fig. 8).
Survival free of myocardial infarction was greater for the
surgically treated patients with both moderate and severe
depression of ventricular function and for the subset with
three vessel disease (Fig. 10 to 12).
Therapeutic implications. Our data confirm the find-
ings of previous studies which indicate that left ventricular
function is an important predictor of survival in patients
with coronary artery disease treated medically or surgically.
In all subsets of patients we examined, survival of surgically
treated patients was significantly greater than that of med-
ically treated patients. In addition, there was a significantly
lower incidence of nonfatal myocardial infarction in the
surgically treated groups. Relief of symptoms was not as-
sessed in this study. The nonrandomized CASS registry ( 10)
compared patients with poor left ventricular function treated
medically and surgically and found that patients with the
predominant symptom of angina were relieved of their
symptoms to a greater extent with surgical therapy. There
was no greater relief of symptoms of heart failure with
surgical therapy. Other reports (19,22-24) of surgical ther-
apy in similar patients have documented substantial relief
of angina. Relief of symptoms of congestive failure and
improvement in left ventricular ejection fraction at rest and
after exercise have been less consistently observed after
bypass grafting (19,23,25,26).
Conclusion. If coronary artery bypass grafting can be
accomplished with an operative risk of less than 5% in
patients with depressed ventricular function, survival and
freedom from nonfatal myocardial infarction will be en-
hanced when compared with medical therapy. It is unlikely
that randomized trials comparing the two forms of therapy
in patients with depressed ventricular function will be con-
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ducted. Until such studies are done and the results known,
we believe that coronary artery bypass grafting should be
applied to this subset of patients if two or more of the major
coronary arteries or their major branches are suitable for
grafting and if the operative mortality does not exceed 5%.
Patients with symptoms of heart failure without angina and
with a diffusely, poorly contracting left ventricle (ejection
fraction < 10 to 15%) appear to be the only exception. The
great majority of patients with angina or without symptoms
should derive substantial benefit from bypass grafting.
We thank Judy Derbyshire for editorial and secretarial assistance.
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